Effects of Lactobacillus casei supplementation on disease activity and inflammatory cytokines in rheumatoid arthritis patients: A randomized double-blind clinical trial

International Journal of Rheumatic Diseases

Volumn 17, Issue 5, 2014, Pages 519-527

  Alipour, Beitullah ^a   Homayouni Rad, Aziz ^a   Vaghef Mehrabany, Elnaz ^a   Sharif, Sakineh Khatoun ^b   Vaghef Mehrabany, Leila ^c   Asghari Jafarabadi, Mohammad ^a   Nakhjavani, Mohammad Reza ^b   Mohtadi Nia, Javad ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

DAS28; EULAR criteria; Inflammatory cytokines; Probiotics; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; PLACEBO; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; BIOLOGICAL MARKER; CYTOKINE;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; DAS28; DIETARY INTAKE; DISEASE ACTIVITY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; LACTOBACILLUS CASEI; MENOPAUSE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; STATE TRAIT ANXIETY INVENTORY; SUPPLEMENTATION; AGED; ARTHRITIS, RHEUMATOID; BLOOD; CLINICAL TRIAL; DISABILITY; IMMUNOLOGY; INTESTINE; IRAN; JOINT; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX; TIME; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; CYTOKINES; DISABILITY EVALUATION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTESTINES; IRAN; JOINTS; LACTOBACILLUS CASEI; MIDDLE AGED; PROBIOTICS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84904299650     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/1756-185X.12333     Document Type: Article

References (43)

1. O'Dell JR (2008) Rheumatoid arthritis. Goldman L, Ausiello D (eds) Cecil Medicine, pp 2003-11. Saunders, Philadelphia.
2. Zyrianova Y (2011) Rheumatoid arthritis: a historical and biopsychosocial perspective. Lemmey AB (ed.) Rheumatoid Arthritis-Etiology, Consequences and Co-morbidities, pp 189. InTech, Rijeka.
3. McCulloch J, Lydyard PM, Rook JAW (1993) Rheumatoid arthritis: how well do the theories fit the evidence? Clin Exp Immunol 92, 1-6.
4. Eerola E, Möttönen T, Hannonen P et al. (1994) Intestinal flora in early rheumatoid arthritis. Br J Rheumatol 33, 1030-8.
5. Malin M, Verronen P, Mykkänen H, Salininen S, Isolauri E (1996) Increased bacterial urease activity in faeces in juvenile chronic arthritis: evidence of altered intestinal microflora? Br J Rheumatol 35, 689-94.
6. Peltonen R, Nenonen M, Helve T, Hanninen O, Toivanen P, Eerola E (1997) Faecal microbial flora and disease activity in rheumatoid arthritis during a vegan diet. Br J Rheumatol 36, 646-8.
7. Scher JU, Abramson SB (2011) The microbiome and rheumatoid arthritis. Nat Rev Rheumatol 7, 569-78.
8. Saarela M, Lahteenmaki L, Crittenden R, Salminen S, Mattila-Sandholm T (2002) Gut bacteria and health foods- the European perspective. Int J Food Microbiol 78, 99-117.
9. Anonymous (2002) Guidelines for the evaluation of probiotics in food, Food and Agriculture Organization of the United Nations and World Health Organization Expert Consultation Report. http://www.who.int/foodsafety/publications/fs_management/ probiotics2/en. 11-1. [Cited 5 January 2012].
10. Cummings JH, Antoine JM, Azpiroz F et al. (2004) PASSCLAIM1-Gut health and immunity. Eur J Nutr 43, 118-173.
11. Delcenserie V, Martel D, Lamoureux M, Amiot J, Boutin Y, Roy D (2008) Immunomodulatory effects of probiotics in the intestinal tract. Curr Issues Mol Biol 10, 37-54.
12. Homayouni-Rad A, Torab R, Mortazavian AM, Vaghef-Mehrabany E, Vaghef-Mehrabany L (2013) Can probiotics prevent or improve common cold and influenza? Nutrition 29, 805-6.
13. Homayouni-Rad A, Torab R, Ghalibaf M, Norouzi S, Vaghef-Mehrabany E (2013) Might patients with immune-related diseases benefit from probiotics? Nutrition 29, 583-6.
14. Kato I, Endo-Tanaka K, Yokokura T (1998) Suppressive effects of the oral administration of Lactobacillus casei on type II collagen-induced arthritis in DBA/1 mice. Life Sci 63, 635-44.
15. So JS, Lee CG, Kwon HK et al. (2008) Lactobacillus casei potentiates induction of oral tolerance in experimental arthritis. Mol Immunol 46, 171-80.
16. So JS, Kwon HK, Lee CG et al. (2008) Lactobacillus casei suppresses experimental arthritis by down-regulating T helper 1 effector functions. Mol Immunol 45, 2692-9.
17. Amdekar S, Singh V, Singh R, Sharma P, Keshav P, Kumar A (2011) Lactobacillus casei reduces the inflammatory joint damage associated with collagen-induced arthritis (CIA) by reducing the pro-inflammatory cytokines. J Clin Immunol 31, 141-54.
18. Baharav E, Mor F, Halpern M, Winberger A (2004) Lactobacillus GG bacteria ameliorate arthritis in Lewis rats. J Nutr 134, 1961-9.
19. Hatakka K, Martio J, Korpela M et al. (2003) Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis- a pilot study. Scand J Rheumatol 32, 212-5.
20. Mandel DR, Eichas K, Holmes J (2010) Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial. BMC Complement Altern Med 10, 1-7.
21. Pineda MA, Thompson SF, Summers K, Leon F, Pope J, Reid G (2011) A randomized, double-blinded, placebo-controlled pilot study of probiotics in active rheumatoid arthritis. Med Sci Monit 17, 343-54.
22. Anal AK, Singh H (2007) Recent advances in microencapsulation of probiotics for industrial applications and targeted delivery. Trends Food Sci Technol 18, 242-51.
23. Perdigon G, Maldonado Galdeano C, Valdez JC, Medici M (2002) Interaction of lactic acid bacteria with the gut immune system. Eur J Clin Nutr 56 (4), S21-6.
24. Aguero G, Villena J, Racedo S, Haro C, Alvarez S (2006) Beneficial immunomodulatory activity of Lactobacillus casei in malnourished mice pneumonia: effect on inflammation and coagulation. Nutrition 22, 818-9.
25. Matsumoto S, Hara T, Hori T et al. (2005) Probiotic Lactobacillus-induced improvement in murine chronic inflammatory bowel disease is associated with the down-regulation of pro-inflammatory cytokines in lamina propria mononuclear cells. Clin Exp Immunol 140, 414-26.
26. Haro C, Villena J, Zelaya H, Alvarez S, Aguero G (2009) Lactobacillus casei modulates the inflammation-coagulation interaction in a pneumococcal pneumonia experimental model. J Inflamm 6, 283-7.
27. Racedo S, Villena J, Medina M, Aguero G, Rodriguez V, Alvarez S (2006) Lactobacillus casei administration reduces lung injuries in a Streptococcus pneumoniae infection in mice. Microbes Infect 8, 2352-66.
28. Baarlen PV, Troost F, Meer CVD et al. (2011) Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways. PNAS 108 (1), 4564-9.
29. Matsuzaki T, Saito M, Usuku K et al. (2005) A prospective uncontrolled trial of fermented milk drink containing viable Lactobacillus casei strain Shirota in the treatment of HTLV-1 associated myelopathy/tropical spastic paraparesis. J Neurol Sci 237 (12), 75-81.
30. Takeda K, Okumura K (2007) Effects of a fermented milk drink containing Lactobacillus casei Strain Shirota on the human NK-cell activity. J Nutr 137, 791S-3S.
31. Homayouni-Rad A (2011) Selection of appropriate probiotic strains in production of functional ice-cream. Microb Biotechnol J Islamic Azad Univ 3, 49-56 (in Persian).
32. Chan ES, Lee PP, Ravindra P, Krishnaiah K, Voo WP (2010) A standard quantitative method to measure acid tolerance of probiotic cells. App Microb Biotechnol 86 (1), 383-91.
33. Both E, Gyorgy E, Kibedi-Szabo CZ et al. (2010) Acid and bile tolerance, adhesion to epithelial cells of probiotic microorganisms. U.P.B Scientific Bulletin Series B 72(2), 37-44.
34. Tuomola E, Salminen SJ (1998) Adhesion of some probiotic and dairy Lactobacillus strains to Caco-2 cell cultures. Int J Food Microbiol 41 (1), 49-51.
35. Wells G, Becker JC, Teng J et al. (2009) Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Ann Rheum Dis 68, 959-60.
36. Fransen J, van Riel PL (2009) The Disease Activity Score and the EULAR response criteria. Rheum Dis Clin North Am 35, 747-57.
37. Ranganath VK, Khanna D, Paulus HE (2006) ACR remission criteria and response criteria. Clin Exp Rheumatol 24, 14-21.
38. Issazadeh-Navikas S, Teimer R, Bockermann R (2012) Influence of dietary components on regulatory T cells. Mol Med 18, 95-110.
39. Borchers AT, Selmi C, Meyers FJ, Keen CL, Gershwin ME (2009) Probiotics and immunity. J Gastroenterol 44, 264-6.
40. Smits HH, Engering A, van der Kleij D et al. (2005) Selective probiotic bacteria induce IL-10 producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3 grabbing nonintegrin. J Allergy Clin Immunol 115, 1261-7.
41. Zhang L, Li N, Caicedo R, Neu J (2005) Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis factor-alpha-induced interleukin-8 production in Caco-2 cells. J Nutr 135, 1751-6.
42. Gill HS, Rutherfurd KJ, Cross ML, Gopal PK (2001) Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am J Clin Nutr 74, 838-9.
43. Chen L, Yang G, Grosser T (2013) Prostanoids and inflammatory pain. Prostaglandins Other Lipid Mediat 104-105, 58-66.